| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
31,206 |
24,960 |
$1.44M |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
8,932 |
8,010 |
$779K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
18,534 |
15,616 |
$581K |
| 95913 |
|
3,593 |
2,975 |
$474K |
| 64635 |
|
2,293 |
1,828 |
$415K |
| 64636 |
|
2,381 |
1,793 |
$323K |
| 95886 |
|
3,904 |
3,235 |
$322K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,211 |
7,822 |
$313K |
| 62323 |
|
2,850 |
2,249 |
$265K |
| 64493 |
|
2,291 |
1,773 |
$225K |
| L0650 |
Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf |
362 |
309 |
$211K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,095 |
1,745 |
$144K |
| 27096 |
|
2,000 |
1,633 |
$142K |
| 64494 |
|
2,427 |
1,746 |
$105K |
| 77002 |
|
1,764 |
1,428 |
$81K |
| 62321 |
|
431 |
332 |
$49K |
| 20610 |
|
1,505 |
1,231 |
$41K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,702 |
607 |
$40K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
9,935 |
7,850 |
$38K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
252 |
210 |
$19K |
| 76942 |
|
745 |
598 |
$18K |
| 64495 |
|
1,425 |
1,023 |
$16K |
| 95912 |
|
134 |
122 |
$16K |
| 64490 |
|
136 |
108 |
$15K |
| 20552 |
|
764 |
586 |
$13K |
| 80305 |
|
1,727 |
1,443 |
$10K |
| 64491 |
|
140 |
107 |
$7K |
| 99215 |
Prolong outpt/office vis |
109 |
91 |
$7K |
| 95887 |
|
140 |
106 |
$4K |
| 20526 |
|
105 |
85 |
$3K |
| 64633 |
|
16 |
14 |
$3K |
| 64634 |
|
18 |
15 |
$3K |
| 97162 |
|
47 |
40 |
$2K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
122 |
72 |
$2K |
| 97161 |
|
34 |
29 |
$2K |
| 72141 |
|
38 |
30 |
$2K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
113 |
54 |
$1K |
| 64418 |
|
36 |
30 |
$1K |
| 64492 |
|
57 |
39 |
$488.58 |
| 20611 |
|
30 |
27 |
$320.30 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
723 |
560 |
$311.19 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
3,737 |
2,954 |
$251.67 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
3,364 |
2,784 |
$0.00 |
| G8867 |
Pneumococcal vaccine not administered or previously received, reason not given |
4,469 |
3,780 |
$0.00 |
| 1123F |
|
1,026 |
816 |
$0.00 |
| G8952 |
Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given |
1,301 |
1,072 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
4,046 |
3,273 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
24 |
14 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
2,391 |
1,988 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
4,863 |
3,821 |
$0.00 |
| 0518F |
|
1,132 |
903 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
2,280 |
1,615 |
$0.00 |
| 1124F |
|
6,610 |
5,319 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
1,330 |
913 |
$0.00 |
| 99490 |
Ccm add 20min |
183 |
95 |
$0.00 |
| G9500 |
Radiation exposure indices documented in final report for procedure using fluoroscopy |
1,082 |
696 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
3,284 |
2,767 |
$0.00 |
| G8864 |
Pneumococcal vaccine administered or previously received |
1,669 |
1,363 |
$0.00 |
| G9584 |
Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy |
18 |
12 |
$0.00 |
| M1316 |
Current tobacco non-user |
42 |
36 |
$0.00 |
| G9276 |
Documentation that patient is a current tobacco user |
46 |
38 |
$0.00 |
| G9562 |
Patients who had a follow-up evaluation conducted at least every three months during opioid therapy |
18 |
12 |
$0.00 |